Melocapsule 7.5 mg (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to up to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg per day depending on the response to treatment. This medicine should not be administered at doses exceeding 15 mg per day and should be taken with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually started at a dose of 7.5 mg per day. ○ Patients with severe renal impairment who are receiving hemodialysis should not be given more than 7.5 mg per day.

This medication may cause gastrointestinal bleeding if taken by individuals who regularly consume more than three alcoholic beverages daily; consultation with a doctor or pharmacist is essential. This medication may increase the risk of cardiovascular diseases and can lead to severe symptoms such as myocardial infarction or stroke; individuals with a history of cardiovascular disease or risk factors should exercise caution. If symptoms such as chest pain, shortness of breath, weakness, or slurred speech occur while taking this medication, discontinue use immediately and consult a healthcare professional. This medication can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, or perforations, so those with a history of gastrointestinal disease or elderly patients should be particularly cautious. If symptoms such as severe rashes, blisters, or damage to mucous membranes occur, discontinue use immediately and inform healthcare professionals. This medication may impact kidney and liver function; those with kidney or liver disease should consult a doctor before use. Women who are pregnant or may become pregnant should not take this medication; women planning to become pregnant are also advised to avoid this medication. Due to potential effects on blood clotting, individuals on anticoagulants should exercise caution and should inform their healthcare provider of any medications they are currently taking, as interactions with other drugs may occur. Elderly patients may have weakened kidney, liver, and heart function, so they should begin treatment with the minimum dose and carefully observe for adverse reactions. During treatment, caution is advised while driving or operating machinery as drowsiness or dizziness may occur. In case of overdose, symptoms such as nausea, vomiting, gastrointestinal bleeding, or in severe cases, renal failure or cardiac issues may arise, necessitating immediate contact with a healthcare provider for appropriate treatment. This medication should be stored out of reach of children and kept tightly closed in its original container.

• Gastrointestinal hemorrhage
• serious cardiovascular thrombotic events
• myocardial infarction
• stroke
• gastrointestinal bleeding or ulcers
• perforation
• exfoliative dermatitis
• Stevens-Johnson syndrome
• toxic epidermal necrolysis
• anaphylactic reaction

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is recommended to store the medication safely at room temperature, between 1 to 30 degrees Celsius.

Appearance

Green hard capsule filled with pale yellow contents

Package unit

30 capsules/bottle, 300 capsules/bottle, 500 capsules/bottle